IL6 and cancer: To confirm the potential involvement of STING signaling in this rapid IL-6 production upon DNA damage, we selected a subset of five cancer cell lines from this panel to which we had access (BT-549, HS-578T, MDA-MB-231, PC-3 and SK-OV-3 cells), that exhibited various profiles of IL-6/ISGs responses.